GlassScriptPhysician profile
Swetha Ramireddy
NPI 1942705108
$2,581.15
in general payments reported to CMS, 2019-2025
14 companies · $506 in 2025
The $506 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $154 · 2022: $90.97 · 2023: $792 · 2024: $1,038 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,336.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $787.77 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $393.42 | 2024-2025 | Impella |
| Medtronic, INC. | $369.54 | 2022-2024 | Turbohawk, Micra |
| Stryker Corporation | $313.64 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Artix Mt |
| Alnylam Pharmaceuticals INC. | $203.75 | 2023 | Amvuttra |
| Astrazeneca Pharmaceuticals LP | $153.87 | 2020-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.30 | 2023 | Jardiance |
| Terumo Medical Corporation | $73.55 | 2023-2025 | Angio-Seal, Tr Band |
| Genzyme Corporation | $41.00 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $38.30 | 2023 | Inpefa |
| Janssen Pharmaceuticals, INC | $32.42 | 2024 | Xarelto |
| Getinge USA Sales, LLC | $25.49 | 2022 | |
| Imperative Care, INC | $21.36 | 2025 | Zoom 88-T Large Distal Platform |
| Lantheus Medical Imaging, INC. | $19.74 | 2023 | Definity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swetha Ramireddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.